DE60124119D1 - Ein thiazolidindionderivat und seine verwendung als antidiabetikum - Google Patents

Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Info

Publication number
DE60124119D1
DE60124119D1 DE60124119T DE60124119T DE60124119D1 DE 60124119 D1 DE60124119 D1 DE 60124119D1 DE 60124119 T DE60124119 T DE 60124119T DE 60124119 T DE60124119 T DE 60124119T DE 60124119 D1 DE60124119 D1 DE 60124119D1
Authority
DE
Germany
Prior art keywords
antidible
indion
thiazolide
derivative
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60124119T
Other languages
English (en)
Other versions
DE60124119T2 (de
Inventor
Simon Craig
Chien Ho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE60124119D1 publication Critical patent/DE60124119D1/de
Publication of DE60124119T2 publication Critical patent/DE60124119T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60124119T 2000-09-07 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum Expired - Fee Related DE60124119T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0021978 2000-09-07
GBGB0021978.2A GB0021978D0 (en) 2000-09-07 2000-09-07 Novel pharmaceutical
PCT/GB2001/003979 WO2002020517A1 (en) 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (2)

Publication Number Publication Date
DE60124119D1 true DE60124119D1 (de) 2006-12-07
DE60124119T2 DE60124119T2 (de) 2007-05-16

Family

ID=9899043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124119T Expired - Fee Related DE60124119T2 (de) 2000-09-07 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (15)

Country Link
US (1) US20040014791A1 (de)
EP (1) EP1315721B1 (de)
JP (1) JP2004508367A (de)
KR (1) KR100769007B1 (de)
CN (2) CN100415741C (de)
AT (1) ATE343574T1 (de)
AU (1) AU2001284274A1 (de)
CY (1) CY1105903T1 (de)
DE (1) DE60124119T2 (de)
DK (1) DK1315721T3 (de)
ES (1) ES2272528T3 (de)
GB (1) GB0021978D0 (de)
HK (1) HK1057204A1 (de)
PT (1) PT1315721E (de)
WO (1) WO2002020517A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
WO2000000195A1 (en) * 1998-06-30 2000-01-06 Takeda Chemical Industries, Ltd. Pharmaceutical composition for the treatment of diabetes

Also Published As

Publication number Publication date
HK1057204A1 (en) 2004-03-19
KR100769007B1 (ko) 2007-10-22
DK1315721T3 (da) 2007-02-19
WO2002020517A1 (en) 2002-03-14
CY1105903T1 (el) 2011-02-02
JP2004508367A (ja) 2004-03-18
DE60124119T2 (de) 2007-05-16
EP1315721B1 (de) 2006-10-25
KR20030031179A (ko) 2003-04-18
AU2001284274A1 (en) 2002-03-22
ES2272528T3 (es) 2007-05-01
US20040014791A1 (en) 2004-01-22
CN1471530A (zh) 2004-01-28
GB0021978D0 (en) 2000-10-25
CN1814599A (zh) 2006-08-09
EP1315721A1 (de) 2003-06-04
PT1315721E (pt) 2007-01-31
ATE343574T1 (de) 2006-11-15
CN100415741C (zh) 2008-09-03

Similar Documents

Publication Publication Date Title
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
YU81501A (sh) Novi farmaceutikal
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
DE60217168D1 (de) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
AP1813A (en) Tartrate salts of thiazolidinedione derivative.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee